October 16, 2023 Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop Neurological disorders represent some of the most challenging therapeutic areas for successful drug approvals.
January 8, 2021 Effective Data Sharing as a Conduit for Advancing Medical Product Development Karpen SR, White JK, Mullin AP, O'Doherty I, Hudson LD, Romero K, Sivakumaran....
September 22, 2017 Biometric Monitoring Devices for Objective Assessments of Relevant Endpoints for Clinical Drug Trials: Key Considerations in Developing an Actionable Eco-system
January 31, 2017 Accelerating drug development for Alzheimer’s disease through the use of data standards
January 31, 2017 Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team